Welcome to Avance Innovations

Revolutionizing the medical device industry with our patented, microsurgical device, ORASIS, about to undergo a randomized clinical trial
Join us in our journey to optimize safety, precision, and costs in the medical field.

Our Product: ORASIS

A game-changing, 3D printed, patented, microsurgical background device, with continuous and autonomous irrigation and suction.

Backed by pre-clinical studies, a clinical trial is now planned to further validate these findings. The IRB paperwork is underway.

Avance Innovations Ltd is currently updating this website to reflect ongoing regulatory and clinical progress for the ORASIS device.

All product information provided on this site is for general informational purposes only and does not constitute marketing, promotion, or sale of the device. 

Features of ORASIS

Discover the innovative features of our patented device.

  • 3D Printed
    Our device is 3D printed, ensuring high quality and precision.
  • Autonomous Irrigation and Suction
    ORASIS, through its patented microfluidic channel underlayer, provides continuous autonomous irrigation and suction for vascular anastomosis.
  • Regulatory status
    ORASIS is an FDA-registered Class I medical device (registration pending renewal fee). The renewal fee will be processed prior to the commencement of the upcoming clinical trial, for which the IRB paperwork is underway. ORASIS has been designed and manufactured in compliance with FDA registration requirements for Class I medical devices

Benefits

Reduced Operative Time

Backed by preclinical publications, ORASIS has the potential to reduce operative time, without surgical assistant required - we will be validating this through the upcoming clinical trial

Cost Savings

Potential for cost savings, if reduction in OR time can be demonstrated in the upcoming clinical trial

Improved Safety and Precision

Our device reduces vessel handling - this may translate to reduce vessel damage and risk of complications - we will validate this in the upcoming clinical study

Partners

  • Selected in the competitive MedTech Innovator Accelerator 2024
  • Endorsed by the American Society of Plastic Surgery (ASPS)
  • Awarded the ASPS Innovation Challenge Prize 2023
  • Selected on to the competitive NHS CEP Programme

The Avance Innovations Team

50+ years experience spanning surgery, medical device development with 30+ patents, regulatory affairs, scientific publishing with 350+ publications, and commercialization.
  • Headshot
    Dr Ankur Khajuria, MD PhD
    Founder & CEO
    Resident Plastic & Reconstructive Surgeon & NHS Clinical Entrepreneur. Led Avance in the US MedTech Innovator Accelerator
  • Jp
    Prof Joon Pio Hong, MD PhD MBA
    Founder & CMO
    Professor of Plastic Surgery and President of the World Society of Reconstructive Microsurgery (WSRM). Chief of International Business Development at Asan Medical Centre (Korea), which led to opening the first international branch GI hospital in Dubai, UAE. Executive board member for Korea’s leading IT company Naver, 2nd largest pharmaceutical company Daewoong and Seoul Semiconductor. 30+ patents
  • Juan cto
    Dr Juan Fernandez, MSc
    CTO
    Bioengineer with expertise in 3D printing, material science, biofabrication, biomechanics and device development

Contact

For general enquiries, and collaboration opportunities, please contact us at:

CEO: ankur@avanceinnovations.com OR CMO: joonpio11@gmail.com

Please note: Avance Innovations Ltd does not currently market, sell, or distribute the ORASIS device

Testimonials

Product feedback

"This will become the standard of care for every micro; like how we now use a coupler device for every venous anastomosis, instead of hand sewn anastomosis"

Microsurgeon, London, UK
Read More

"ORASIS will be a game-changer - especially in private practice, where the surgeon can do the micro themselves, and the assistant can close the donor site at same time, massively cutting operative time."

Microsurgeon, London, UK

Submission Successful

The form has been successfully submitted.

Built on Unicorn Platform